Recent & Archived News
February 15, 2019
Bayer to obtain full rights to global development and commercialization of oncology compounds Vitrakvi® (larotrectinib) and BAY 2731954 (LOXO-195)
Bayer has exercised its option, under a change-in-control clause in the collaboration agreement with Loxo Oncology, to obtain the exclusive licensing rights for the global development and...
February 14, 2019
Bayer's investigational drug darolutamide plus androgen deprivation therapy (ADT) significantly extends metastasis-free survival compared to placebo plus ADT in non-metastatic castration-resistant prostate cancer
Results from the pivotal Phase III ARAMIS trial in patients with non-metastatic castration-resistant prostate cancer (nmCRPC) showed a statistically significant improvement in metastasis-free...
February 13, 2019
Bayer donates $130,000 to 13 domestic violence shelters through new Grants Fur Families program
Bayer announces 13 domestic violence shelters that are receiving funding through Grants Fur Families, a new program providing life-saving support to domestic violence shelters across the country...
February 13, 2019
Bayer and Geisinger partner to create contraception counseling pathway to improve overall contraceptive care for women
Bayer, a longstanding leader in women's healthcare, and Geisinger are partnering to create a contraception counseling pathway within the Geisinger Electronic Health Record (EHR) with the aim of...
February 07, 2019
Bayer's Ray Kerins Elected Chairman of U.S. Chamber of Commerce's Global Innovation Policy Center
Bayer U.S. announced today that Raymond F. Kerins, Jr., Senior Vice President of Corporate Affairs, is the new Chairman of the U.S. Chamber of Commerce's Global Innovation Policy Center (GIPC). In...
February 05, 2019
Bayer to Showcase New Data from its Growing Cancer Portfolio at 2019 ASCO GU Cancers Symposium
Bayer announced today that research on its growing cancer portfolio will be presented at the 2019 American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium taking place...
January 31, 2019
Monsanto Fund and Operation Food Search Unveil New Nutritional Program Focused on Healthy Pregnancies
To address issues associated with food insecurity during pregnancy for low-income women and their families, the Monsanto Fund (a philanthropic arm of Bayer) and St. Louis-based Operation Food...
January 18, 2019
Bayer introduces versatile new option for heartworm prevention and intestinal parasite control
Bayer Animal Health announces the launch of Coraxis™ (moxidectin) Topical Solution for Dogs, a prescription-only, monthly transdermal product that prevents heartworm disease and treats and...
January 17, 2019
Farm for the Good™ of Your Community
Growers, the economic drivers of our rural economies, can kick in a power thrust with the Farm for Good™ Sweepstakes, presented by Bayer. Growers now can enter for a chance to win a $5,000...
January 16, 2019
Bayer to Highlight New Research at ASCO GI 2019 Cancers Symposium
Bayer will present new data from its continued research on Stivarga® (regorafenib) in metastatic colorectal cancer (mCRC) and metastatic biliary tract cancers, and Nexavar® (sorafenib) in...
Want even more Bayer news?
Last Updated: December 14, 2018